Interleukin 4 receptor (IL-4R/IL-4Ra): a Multifunctional Target of Cytokines, Suggesting Diverse Potential in Asthma, Rhinitis, Viral, and Tumor Research!
Interleukin 4 receptor (IL-4R/IL-4Ra): a Multifunctional Target of Cytokines, Suggesting Diverse Potential in Asthma, Rhinitis, Viral, and Tumor Research!On January 26, 2024, a pharmaceutical company license two promising products: an anti-TSLP monoclonal antibody and an anti-IL-4Ra monoclonal antibody. These aim to treat respiratory disorders like asthma and chronic obst...
Detailed information

In Vivo vs. In Vitro: Choosing the Right Experimental Model for Your Research
In Vivo vs. In Vitro: Choosing the Right Experimental Model for Your ResearchResearchers conduct experiments using various experimental models, which can be categorized into two main types: in vivo and in vitro. Selecting the appropriate experimental model is paramount in scientific studies invol...
Detailed information

Dipeptidase 3 (DPEP3): an Emerging Member of the DPEP Family, a Potential Therapeutic Target in Male Fertility or Tumor Research!
Dipeptidase 3 (DPEP3): an Emerging Member of the DPEP Family, a Potential Therapeutic Target in Male Fertility or Tumor Research!On March 15, 2024, the Journal of Affective Disorders published a study delving into the molecular mechanisms of post-traumatic stress disorder (PTSD) and major depression (MDD). The research revealed a notable decrease ...
Detailed information

CEACAM8: a Member of CEA Family, Emerging as a Vital Player in Gynaecological or Gastrointestinal Cancer Research!
CEACAM8: a Member of CEA Family, Emerging as a Vital Player in Gynaecological or Gastrointestinal Cancer Research!In February 2024, the Elsevier database published a article based on bioinformatics analysis. This study identified 42 differentially expressed genes through transcriptomic analysis of multiple sclerosis patients during ...
Detailed information

CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors!
CD70 (CD27L/TNFSF7): a TNF Receptor Member, a “Star” Target for Clinical Research in Systemic Lupus Erythematosus (SLE), Arthritis, and Tumors!On January 27, 2024, a study published in the Journal of Autoimmunity explored the impact of CD70 methylation on systemic lupus erythematosus (SLE), revealing elevated levels in SLE patients' CD4+ T cells, potentially li...
Detailed information

Serotransferrin/TF: a Major Transferrin in Plasma, a Novel TF-Modified Nanoparticle for Tumor-Targeting Research!
Serotransferrin/TF: a Major Transferrin in Plasma, a Novel TF-Modified Nanoparticle for Tumor-Targeting Research!In January 2024, a research paper titled "Remyelinating effect driven by transferrin-loaded extracellular vesicles" was included in the Scholar database [1]. The study explored using extracellular vesicles (EVs) as carri...
Detailed information

Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research?
Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research?Myosin-regulated light chains (MLCs/MRLCs) constitute crucial elements within Myosin II, exerting significant influence on diverse life processes such as muscle contraction and cell division. Recent investigations have u...
Detailed information

CCR9: A Member of the Chemokine Receptor Family, an Emerging Target for Numerous Tumor Researches!
CCR9: A Member of the Chemokine Receptor Family, an Emerging Target for Numerous Tumor Researches!Chemokine receptors, a type of G protein-coupled receptors, are increasingly recognized for their role in various biological processes. They impact normal growth, development, inflammatory responses, immunity, and diseas...
Detailed information

Chemokine Receptor CCR6: the Specific Receptor for CCL20, a Potential Target for Drug Research in Inflammatory Diseases and Gastrointestinal Cancer!
Chemokine Receptor CCR6: the Specific Receptor for CCL20, a Potential Target for Drug Research in Inflammatory Diseases and Gastrointestinal Cancer!On January 3, 2024, a recent review titled "Research progress on the role of tumor-associated macrophages in tumor development and their use as molecular targets" sheds light on the pivotal role of tumor-associated macro...
Detailed information

ACVRL1 (Alk1): a Member of the TGF-β Receptor Family, a Novel Target for Anti-Angiogenic Drug Research!
ACVRL1 (Alk1): a Member of the TGF-β Receptor Family, a Novel Target for Anti-Angiogenic Drug Research!Lately, the journal Nature Communications published a paper entitled "Alk1 acts in non-endothelial VE-cadherin+ perineurial cells to maintain nerve branching during hair homeostasis" [1], emphasizing the importance of TG...
Detailed information

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalizationX